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Abstract
In many bacterial species, including the aquatic bacterium and human pathogen Vibrio cho-
lerae, the second messenger cyclic diguanylate (c-di-GMP) modulates processes such as
biofilm formation, motility, and virulence factor production. By interacting with various effec-
tors, c-di-GMP regulates gene expression or protein function. One type of c-di-GMP recep-
tor is the class I riboswitch, representatives of which have been shown to bind c-di-GMP in
vitro. Herein, we examined the in vitro and in vivo function of the putative class I riboswitch
in Vibrio cholerae, Vc1, which lies upstream of the gene encoding GbpA, a colonization fac-
tor that contributes to attachment of V. cholerae to environmental and host surfaces contain-
ing N-acetylglucosamine moieties. We provide evidence that Vc1 RNA interacts directly
with c-di-GMP in vitro, and that nucleotides conserved among this class of riboswitch are
important for binding. Yet the mutation of these conserved residues individually in the V.
cholerae chromosome inconsistently affects the expression of gbpA and production of the
GbpA protein. By isolating the regulatory function of Vc1, we show that the Vc1 element
positively regulates downstream gene expression in response to c-di-GMP. Together these
data suggest that the Vc1 element responds to c-di-GMP in vivo. Positive regulation of
gbpA expression by c-di-GMP via Vc1 may influence the ability of V. cholerae to associate
with chitin in the aquatic environment and the host intestinal environment.
Introduction
Cyclic diguanylate (c-di-GMP) is a ubiquitous second messenger important for bacterial adap-
tation to environmental conditions. In response to largely undefined signals at the cell surface,
changes in intracellular c-di-GMP concentration relays that information to target intracellular
effectors, regulating processes such as biofilm formation, motility and virulence gene expres-
sion (reviewed in [1]). The intracellular level of c-di-GMP is controlled by the activities of
diguanylate cyclases (DGCs) and phosphodiesterases (PDEs), enzymes responsible for the syn-
thesis and degradation of c-di-GMP, respectively [2–8]. Bacterial genomes often contain
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multiple genes encoding putative DGC and PDE enzymes, potentially reflecting a requirement
for tight regulation of c-di-GMP levels and the need to modulate c-di-GMP in response to
diverse extracellular cues.
Various classes of intracellular c-di-GMP receptors have been identified and can control c-
di-GMP regulated processes via transcriptional, post-transcriptional or post-translational
mechanisms. In addition to numerous protein sensors of c-di-GMP, post-transcriptional regu-
lation by c-di-GMP can occur through riboswitches, cis acting regulatory elements found in
the 5’ untranslated region (UTR) of some mRNAs [9–11]. Two types of c-di-GMP sensing
riboswitches have been identified, class I and class II [9,12]. The two classes share no structure
or sequence homology. The class I c-di-GMP riboswitches contain a GEMMmotif, which is
widespread in bacteria and so named because it often resides in the 5’UTR of genes with func-
tions predicted to relate to the environment, membrane or motility [9,13]. Based on the co-
crystal structure of c-di-GMP with the V. cholerae aptamer Vc2, GEMMmotifs are predicted
to contain two adjacent stem-loops, termed P2 and P3, a tetraloop-tetraloop receptor motif
that stabilizes the interaction between P2 and P3, and a P1 stem that forms through base pair-
ing between the flanking 5’ nucleotides of P2 and the flanking 3’ nucleotides of P3 [9,11,13].
The nucleotides of Vc2 that contact c-di-GMP lie at the junction of P1, P2, and P3.
Only a few studies have directly addressed the functionality of a c-di-GMP riboswitch in
vivo, in its native genetic context, and the impact of c-di-GMP sensing on the physiology of a
bacterium. Clostridium difficile encodes numerous putative c-di-GMP riboswitches (both class
I and class II), some of which lie upstream of genes encoding surface proteins and organelles
such as flagella and Type IV pili [9,12]. Artificial elevation of c-di-GMP in C. difficile represses
flagellar gene expression and swimming motility [14–16]. These findings are consistent with
prior work showing that the GEMM riboswitch Cd1 upstream of a flagellar operon functions
as an “off switch” in response to c-di-GMP; mutations in Cd1 that impair its interaction with
c-di-GMP result in increased reporter gene expression in a heterologous bacterial host [9].
Conversely, the class II riboswitch upstream of a pilin gene functions as an “on switch” in
response to c-di-GMP in C. difficile [17]. C-di-GMP positively regulates type IV pilin gene
expression through direct interaction with the riboswitch, promoting cell aggregation, biofilm
formation and surface motility [17,18]. Recently, the production of a zinc metalloprotease,
ZmpI, and one of its targets, the C. difficile surface protein CD2831, have been shown to be reg-
ulated by c-di-GMP in vivo [19]; these findings are consistent with the presence of class II c-di-
GMP riboswitches upstream of the respective genes [12,20].
The biochemistry and function of the second predicted GEMM riboswitch in V. cholerae,
called Vc1, has not been examined. The predicted GEMMmotif of Vc1 has 75% overall iden-
tity with the well-characterized Vc2 GEMMmotif, with 85% identity in the region that encodes
the first stem-loop, P2. The residues that contact the c-di-GMP ligand in Vc2 (G20, A47 and
C92) are conserved in Vc1 (G12, A39, and C104, respectively). The nucleotides that form the
interhelical Watson-Crick base pair, universally conserved among GEMM riboswitches, are
also present in Vc1 (C36 and G90 in P2 and P3 of Vc1, respectively). While critical features of
the GEMM riboswitch are conserved in Vc1, the differences between Vc2 and Vc1 may help
define broadly the mechanisms by which c-di-GMP acts through GEMM riboswitches.
Vc1 lies upstream of gbpA, which encodes a well-characterized colonization factor that is
well conserved among V. cholerae environmental and clinical isolates [21]. GbpA is a secreted
protein that aids in colonization of surfaces in aquatic environments (the natural habitat of V.
cholerae) and the small intestine (the tissue colonized by pathogenic V. cholerae) [22]. GbpA
recognizes chitin, a polymer of N-acetylglucosamine (GlcNAc) found in the exoskeletons of
zooplankton and crustaceans colonized by V. cholerae in aquatic reservoirs [22]. GbpA also
plays a role in colonization of the small intestine by interacting with GlcNAc present in mucin
Regulation by a Putative c-di-GMPRiboswitch in V. cholerae
PLOSONE | DOI:10.1371/journal.pone.0148478 February 5, 2016 2 / 17
Competing Interests: The authors have declared
that no competing interests exist.
and on the surface of intestinal epithelial cells [22,23]. In vitro studies have shown that GbpA
selectively interacts with GlcNAc oligomers and polymers [24]. Accordingly, V. cholerae
mutants lacking gbpA are attenuated both in an animal model of infection and attachment to
chitinous surfaces [22,23]. Studying Vc1 may thus provide insight about the role of c-di-GMP
and Vc1 in modulating attachment of V. cholerae to environmental and host surfaces.
In this study, we combine biochemical and genetic approaches to evaluate the Vc1 element
for function as a riboswitch that controls gbpA expression in response to c-di-GMP. We pro-
vide evidence that Vc1 directly interacts with c-di-GMP in vitro, and interfering with Vc1 sens-
ing of c-di-GMP impairs downstream gene expression in vivo. Furthermore, using a Vc1
reporter gene fusion under the control of a heterologous, constitutive promoter shows that Vc1
is a c-di-GMP responsive RNA element. These data suggest that c-di-GMP signaling through
Vc1 promotes gbpA expression and GbpA-dependent adherence to host and environmental
surfaces.
Materials and Methods
Growth conditions and media
V. cholerae C6706 and isogenic mutant strains (S1 Table) were cultured at 37°C in Luria-Ber-
tani (LB) broth containing 100 μg/ml streptomycin (Sm), 10μg/ml chloramphenicol (Cm),
and/or 50 μg/ml ampicillin (Amp), as appropriate.
Artificial manipulation of intracellular c-di-GMP
The manipulation of the intracellular level of c-di-GMP in V. cholerae was achieved as
described previously [25,26]. Briefly, overnight cultures of V. cholerae harboring pBAD33
(“vector”), pBAD33::vieA (“pPDE”), pBAD33::vieA-E170A (“pPDEmut”) or pBAD33::
VCA0956 (“pDGC”) were back-diluted 1:100 in LB-Cm broth and grown at 37°C with shaking.
Induced cultures contained 0.2% L-arabinose unless otherwise specified. Samples were col-
lected for western blotting, β-galactosidase assays and/or qRT-PCR analysis as described
below.
5’ Rapid Amplification of cDNA Ends (RACE)
RNA was collected using TRIsure (Bioline) and the RNeasy kit (Qiagen) as described previ-
ously [27]. A gbpA specific primer, gbpAsp1, was used to make cDNA from RNA in a reverse
transcription reaction with the Tetro cDNA Synthesis Kit (Bioline), using the manufacturer’s
protocol. Next, Terminal transferase, TdT (NEB), was added to the reaction to introduce a
homopolymeric A sequence to the 5’ end the cDNAmolecules, using the manufacturer’s proto-
col. PCR using nested primers specific to the 5’ homopolymeric tail (Race1g, Race1c, Race1a)
and gbpA (gbpAsp2) were used to amplify the cDNA products. Sequencing of amplified cDNA
products identified the +1 site of transcription.
Genetic manipulations
Strains and plasmids used in this study are listed in S1 Table. All oligonucleotide primers used
for cloning are listed in S2 Table. Details regarding the generation of strains used in this study
are described in the Supplemental Methods (S1 File).
GbpA antibody production
Anti-GbpA antiserum was produced by Yenzym 192 Antibodies, LLC, South San Francisco,
CA. Antiserum was raised in rabbits to a synthetic peptide (CSNATQYQPGTGSHWEMAWDKR)
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that corresponds to GbpA from V. cholerae. The animal facilities were NIH/OLAW/PHS
assured, USDA certified, and IACUC regulated.
Western blot analysis
Overnight cultures were diluted 1:100 and grown in LB broth at 37°C with aeration until mid-
exponential phase (OD600 ~ 0.6–0.8). Equal volumes of supernatant, normalized to OD600,
were collected, and proteins were precipitated using 10% trichloroacetic acid (TCA). TCA-pre-
cipitated samples were separated by electrophoresis, transferred onto nitrocellulose mem-
branes, and probed with rabbit anti-GbpA antibodies. Goat anti-rabbit IgG conjugated with
IR800 dye (Thermo Scientific) was used as the secondary antibody. Membranes were imaged
using an Odyssey imaging system (LI-COR). At least three independent experiments were per-
formed, and a representative image is presented. Densitometry analyses were carried out using
Odyssey software by normalizing the intensities of the bands corresponding to GbpA to those
of a cross reactive band that did not change intensity in any of the strains or conditions tested
(indicated by asterisks in relevant images).
In vitro transcription
For SHAPE analysis, V. cholerae C6706 genomic DNA was used as the template in PCR with
primers T7linkF + T7R, yielding a product consisting of the T7 promoter and the -15 to +665
portion of the gbpA transcript. The PCR product was used as template for in vitro transcription
of the RNA using the Ambion MEGAscript1 T7 Kit, according to the manufacturer’s instruc-
tions. The RNA was precipitated with ethanol and suspended in water. RNAs were resolved on
a denaturing 6% polyacrylamide gel (1X TB, 7M urea, 6% acrylamide). The desired RNA bands
were excised from the gel and placed in RNase-free water overnight at 4°C to elute the RNA.
The eluted material was ethanol precipitated to recover RNA, and the RNA was suspended in
TE buffer.
For equilibrium dialysis, the templates used for the transcription reactions were amplified
from genomic DNA of C6706 and Vc1 mutant derivatives using T7Vc1F + Vc1R3. Vc2WT and
Vc2G20T were amplified from C6706 genomic DNA and pCVD442::Vc2G20T, respectively,
using T7Vc2F + T7Vc2R. RNA was transcribed from the resulting DNA as described above,
yielding products with the T7 promoter and the -15 to +140 region of the gbpA 5’UTR (Vc1
and Vc1G12U; numbering according to 5’ RACE results) or the -2 to +209 region of the VC1722
transcript (Vc2 and Vc2G20U; numbering according to the 3IRW entry in PDB).
SHAPE analysis of the gbpAmRNA
Vc1 RNA (10 μl, 7 μM) was denatured by heating at 95°C for 2 minutes and snap-cooled on ice
for 2 minutes. RNA (2 μl) was combined with 6 μl of 3.3× folding buffer (33 mMHEPES, 333
mMMgCl2, 333 mM NaCl, pH 8), 2 μl of water and either 10 μl of water or 10 μl of 1 mM c-di-
GMP [28]. The RNA was folded at 37°C for 30 min. Folded RNA (9 μl) was added to 1 μl of 30
mM 1M7 (in DMSO) or to 1 μl DMSO only, immediately mixed thoroughly, and incubated at
37°C for 3 min. RNA was precipitated with ethanol and suspended in TE buffer. SHAPE
adducts were detected by primer extension as described [29]. 1M7 and DMSO treated RNA, as
well as untreated RNA (later used for sequencing), were mixed with fluorescently labeled DNA
oligonucleotides that anneal to gbpA (Vc1SHAPE_R). Primer extension was initiated by addi-
tion of Superscript III reverse transcriptase (Invitrogen). Sequence information was generated
using unmodified RNA by performing primer extension in the presence of dideoxynucleotide
triphosphates (ddNTPs). Primer extension products were ethanol precipitated and suspended
in formamide. Products were resolved on an ABI 3500 capillary electrophoresis instrument
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and analyzed using QuShape [30]. Each experiment was performed at least three times, and
statistical significance was determined using Student’s t-test.
Synthesis of radiolabeled c-di-GMP
Radiolabeled c-di-GMP was generated as detailed previously [7,14]. Briefly, c-di-GMP32 was
synthesized in vitro using recombinant diguanylate cyclase WspR (from Pseudomonas aerugi-
nosa) [31], with [α-32P]GTP as the substrate (Perkin-Elmer Life Sciences). The presence and
yield of the c-di-GMP32 reaction product was confirmed by thin layer chromatography, and c-
di-GMP32 was purified using Ultrafree-MC 5000 Da molecular weight cut-off columns (Cen-
tricon) [7].
Equilibrium dialysis
In vitro transcribed Vc1, Vc1G12U, Vc1A39U, Vc1C104G, Vc2 and Vc2G20U RNA were denatured
by heating at 95°C for 2 minutes and snap-cooled on ice for 2 minutes. RNA was then com-
bined with 4 μl of 5X folding buffer (50 mMHEPES, 500 mMMgCl2, 500 mMNaCl, pH 8)
and added in a 20 μl total volume to chamber A of a two-chamber equilibrium dialysis device
with a 5000 Da MWCOmembrane (Dispo Equilibrium Dialyzer, Harvard Apparatus). c-di-
GMP32 was combined with 4 μl of 5× folding buffer and added in a 20 μl total volume to cham-
ber B of the equilibrium dialysis device. The final concentrations of RNA and ligand in the
binding reactions were: 3.33 nM c-di-GMP32, 30 μMVc1 and mutant derivatives, and 10 μM
Vc2 and Vc2G20U. Samples were allowed to equilibrate for 22 hours, and then 2 μl were
removed for scintillation counting. For each RNA, the products of two separate transcription
reactions were tested in triplicate, and the data were combined. For competition experiments,
following 10 hours of equilibration with ligand (or controls), the contents of chamber B were
removed and replaced with 100 μMGTP or 100 μM c-di-GMP diluted in 5X folding buffer.
Samples were allowed to equilibrate for an additional 10 hours, then 2 μl were removed for
scintillation counting. Binding was calculated as the percentage of the total radioactivity pres-
ent in the chamber (A) containing RNA. If no binding of c-di-GMP32 occurs, c-di-GMP32 will
distribute equally between the two chambers; if RNA capable of binding c-di-GMP32 is present,
c-di-GMP32 will accumulate in that chamber. Each experiment was repeated independently at
least three times.
RNA isolation and quantitative real-time PCR
Transcriptional analyses by quantitative reverse transcriptase PCR (qRT-PCR) were done
essentially as previously described, using mid-exponential phase (OD600 ~ 0.5–0.7) cultures
[27]. For cDNA synthesis, 200 ng of RNA was reverse transcribed using the Tetro cDNA Syn-
thesis Kit with random hexamers as primers (Bioline). As negative controls, reactions were run
without reverse transcriptase. cDNA samples were combined with 2× SYBR/fluorescein mix
(SensiMix; Bioline), 7.5 μM of each primer (RPB2F + RPB2R for rpoB, gbpAqF2 + gbpAqR2
for the gbpA ORF) (S2 Table). The reactions were run using a MyiQ thermocycler (Bio-Rad)
and the following program: 95°C for 10 min, followed by 40 cycles of 95°C for 30 s, 55°C for 1
min, and 72°C for 30 s. Melt curves were performed to verify the amplification of single prod-
ucts, and all values were adjusted for primer binding efficiency, as calculated from a standard
curve of C6706 genomic DNA. Data were analyzed using the ΔΔCt method, with values nor-
malized to the specified reference strain/condition, and transcript levels normalized to those of
the housekeeping gene rpoB in each sample. For each strain a minimum of three biological
samples was tested. Statistical significance was determined by unpaired t-test.
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Beta-galactosidase assays
Dilutions of stationary phase cultures (grown 12–16 hours at 37°C with aeration) were assayed
for β-galactosidase activity using ortho-nitrophenyl-β-D-galactoside as a substrate as described
previously [32]. At least three independent experiments were done and the data were combined
and analyzed by unpaired t-tests.
Results
The predicted structure and c-di-GMP binding sites of Vc1
To begin analyzing the Vc1 element predicted upstream of the gbpA open reading frame
(ORF), we first defined the 5’UTR of gbpA by identifying the transcriptional start site using 5’
Rapid Amplification of cDNA Ends (5’ RACE). To rule out potential differences in the length
of the gbpA 5’UTR in response to c-di-GMP, 5’ RACE was performed with RNA collected
from strains with both wild type and low c-di-GMP levels. The intracellular level of c-di-GMP
in V. cholerae was reduced by ectopic expression of a c-di-GMP PDE as described previously
[33]. Briefly, V. cholerae harboring a plasmid that allows inducible expression of the well-char-
acterized c-di-GMP PDE, VieA, was used to test the effect of depleting intracellular c-di-GMP
[7,25,33]. V. cholerae containing vector only, treated identically to V. cholerae with pPDE,
serves as an unperturbed “wild-type” c-di-GMP control. 5’ RACE showed that the transcrip-
tional start site (+1) remains unchanged between V. cholerae with native and low c-di-GMP
levels and is 225 nucleotides upstream of the annotated translational start site of gbpA (Fig 1A).
The predicted GEMMmotif of Vc1 is thus encoded within the first 111 nucleotides of the gbpA
5’ UTR. Using this information and the GEMM consensus sequence and structure, the RNA
structure of the first 120 bases of the gbpA 5’UTR, which encompass the GEMMmotif of Vc1,
was modeled and is consistent with the accepted secondary structure of Vc2 (Fig 1A and 1B)
[9,11].
Mutations in predicted c-di-GMP contact residues of Vc1 affect
downstream gene expression
To examine the role of Vc1 in regulating gene expression in response to c-di-GMP, we con-
structed a translational reporter consisting of the gbpA 5’ UTR fused to lacZ from Escherichia
coli (S1 Fig). The heterologous promoter Plac drove expression, allowing constitutive, PgbpA-
independent transcription initiation during growth in rich medium. We generated four deriva-
tives of the reporter plasmid, each with a mutation in Vc1 predicted to interfere with sensing c-
di-GMP. The “Vc1P1” derivative contains mutations in five consecutive nucleotides in Vc1:
C4G, A5T, C6G, A7T, C8G. In Vc2, these five nucleotides comprise the P1 stem that forms in
the presence of c-di-GMP. The other three mutant reporters each contain a single point muta-
tion in a nucleotide predicted to interact directly with the c-di-GMP ligand: G12T, A39T and
C104G (noted in Fig 1A and 1B) [11]. The plasmids were introduced into V. cholerae, and
reporter activity was measured using a β-galactosidase assay. Relative to the wild type reporter,
the Vc1P1, G12T and A39T mutations significantly reduced, but did not eliminate, β-galactosi-
dase activity (Fig 2A). These results suggest that G12 and A39 may be important for sensing c-
di-GMP and for full expression of the downstream gene. Conversely, the C104G mutation
caused a modest increase in β-galactosidase activity, suggesting it is not required for sensing c-
di-GMP. An alternate mutation, C104A, was made, but this mutation also did not have an
effect on β-galactosidase activity (data not shown).
We next assessed the functionality of Vc1 in its native genetic context. The four mutations
described above, P1, G12T, A39T and C104G, were individually introduced into the
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chromosomal Vc1 in V. cholerae C6706 via allelic exchange, and GbpA production was mea-
sured by western blot. A strain with an in-frame deletion of gbpA served as a control. Consis-
tent with the β-galactosidase reporter assays, the level of GbpA decreased significantly in the
P1 and G12T mutants (Fig 2B and 2C). GbpA protein abundance was not significantly altered
in the A39T and C014G mutants. In addition, the effects of each chromosomal point mutation
on GbpA production mirrored the effects of the mutations in the extrachromosomal transcrip-
tional reporter. Thus, although each of the equivalent nucleotides plays critical roles in c-di-
GMP in Vc2 binding in vitro, the G12 mutation in Vc1 has the largest impact on downstream
gene expression in vivo.
Fig 1. Vc1 secondary structure and putative contact residues for c-di-GMP. (A) The +1 site of
transcription, which is 244 base pairs upstream of the experimentally determined translational start site (S1
Fig), was identified using 5’RACE. Vc2 and Vc1 were aligned using ClustalW2. The alignment begins with
the +1 transcriptional start site for Vc1 and the nucleotide at position +9 according to the sequence annotation
for Vc2 (PDB 3IRW [11]). Asterisks represent nucleotides that are conserved between Vc1 and Vc2.
Nucleotides bolded and underlined are contact residues for c-di-GMP in Vc2 and are predicted contact
residues for c-di-GMP in Vc1. The regions predicted to encode P2 and P3 are labeled. (B) The predicted
structure of Vc1 based on an alignment with Vc2 and the consensus GEMM aptamer structure. The predicted
tetraloop and tetraloop receptor are noted.
doi:10.1371/journal.pone.0148478.g001
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Fig 2. Vc1 influences downstream gene expression. (A) β-galactosidase activity of V. cholerae strains
with plasmid-borne lacZ translational fusions to wild type Vc1 or mutant derivatives. Transcription initiation is
controlled by the lac promoter. Three independent experiments were done, and the means and standard
deviations are shown. *** P < 0.001, * P < 0.05 by unpaired t-test. (B) Western blot analysis of the GbpA
levels in the supernatants of cultures of wild type V. cholerae, an isogenic ΔgbpA strain, or strains with
mutations in Vc1 (P1, G12T, A39T, or C104G). The image shown is representative of three independent
experiments. (C) Densitometry of the western blots was done by comparing the intensity of the GbpA band to
that of a cross-reactive band in the same lane (indicated by an asterisk), and then normalizing to the wild type
values. Shown are the means and standard deviations for three independent experiments. *** P < 0.001 by
unpaired t-test.
doi:10.1371/journal.pone.0148478.g002
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Evidence that Vc1 interacts directly with c-di-GMP in vitro
To test whether Vc1 interacts with c-di-GMP, we used several approaches. First, we used selec-
tive 2’-hydroxyl acylation analyzed by primer extension (SHAPE) chemistry to probe the
potential interaction between Vc1 and c-di-GMP [34]. SHAPE uses acylating agents, such as
1-methyl-7-nitroisatoic anhydride (1M7), which selectively form adducts at the 2’-hydroxyl
group of an RNA nucleotide. The ability of 1M7 to react with a nucleotide depends on the local
flexibility of that nucleotide within an RNA structure, and flexibility correlates with the extent
to which a nucleotide is constrained within a structure [35]. SHAPE has been used successfully
to assess the interactions between several riboswitches and their target ligands, including the
Vc2 aptamer and c-di-GMP [29,36]. A comparison of structures for a GEMM riboswitch in
the presence and absence of c-di-GMP has not been reported to date, and we used SHAPE
chemistry to assess the differences between apo-Vc1 and Vc1 with c-di-GMP.
An in vitro transcript of the gbpAmRNA, encompassing the entire 5’UTR of gbpA and 440
bases of the open reading frame (ORF), was folded in the presence or absence of c-di-GMP,
subjected to 1M7 modification, and analyzed by SHAPE. An RNA sequence that extends
downstream of the Vc1 aptamer was used because of the possibility that neighboring RNA
sequence impacts the structure of the riboswitch. Statistically significant differences in reactiv-
ity were observed in three distinct regions of the GEMMmotif in the presence and absence of
c-di-GMP (Fig 3, asterisks). Reactivity of nucleotides U9, U10, and U11, located adjacent to the
first predicted c-di-GMP contact residue G12, significantly increased in the presence of c-di-
GMP. A40 showed a decrease in reactivity in the presence of c-di-GMP and is adjacent to the
second predicted contact residue for c-di-GMP, A39. An increase in reactivity in the presence
of c-di-GMP was also observed in region immediately 5’ of Vc1; in Vc2, this region contributes
to the “P1” stem formed in the presence of c-di-GMP [9,11]. No changes were observed near
or around C104. As a control, we performed SHAPE with Vc1 with and without another
Fig 3. c-di-GMP impacts the SHAPE reactivity of specific regions in Vc1 RNA. Vc1 RNA transcripts were incubated with or without 500 μM c-di-GMP
and analyzed by SHAPE. SHAPE reactivity values for each nucleotide position were obtained by averaging values from five independent experiments. The
inset shows in red text the location of the nucleotides with significantly altered reactivity, mapped on the predicted structure of Vc1. The boxes denote the
G12, A39 and C104 residues. * P < 0.05 by unpaired t-test comparing SHAPE reactivity values for each nucleotide position, with or without c-di-GMP,
indicating significant changes in reactivity in response to c-di-GMP.
doi:10.1371/journal.pone.0148478.g003
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guanosine nucleotide, GTP. No statistically significant differences in Vc1 reactivity were
observed in the presence of GTP relative to apo-Vc1, indicating that GTP and Vc1 do not inter-
act (S2 Fig). Together these results suggest that c-di-GMP specifically interacts with Vc1 via
the G12 and A39 regions, but not the C104 region, though indirect effects of c-di-GMP on the
reactivity of the G12 and A39 regions are also possible.
We next used equilibrium dialysis to assess the interaction between Vc1 RNA and c-di-
GMP. As expected, when no RNA was added, c-di-GMP32 was detected equally in both cham-
bers; Vc2 RNA, which served as a positive control, sequestered c-di-GMP32 (Fig 4A) [9–11,37].
Vc1 RNA also sequestered c-di-GMP32, but less so than Vc2 RNA (71% versus 83% of c-di-
GMP in the RNA chamber, respectively), suggesting that Vc1 RNA binds c-di-GMP but per-
haps with a lower affinity than Vc2 (Fig 4A).
Fig 4. Vc1 directly and specifically interacts with c-di-GMP. (A) Binding of c-di-GMP32 to in vitro
transcribed Vc1 RNA and mutant derivatives was measured by equilibrium dialysis as described in the
Materials and Methods. Vc2 and Vc2G20U RNA were included as controls, and no-RNA samples were used
as a negative control. (B) The specificity of binding to c-di-GMP to Vc1 and Vc2 RNA was assessed by
equilibrium dialysis, allowing c-di-GMP32 to bind and reach equilibrium as the first measurement (black bars),
then competing with unlabeled, excess c-di-GMP or GTP and determining the percentage of c-di-GMP32
retained in the RNA chambers (grey bars). **P < 0.01, **P < 0.001 by unpaired t-test.
doi:10.1371/journal.pone.0148478.g004
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We next evaluated the binding of c-di-GMP to the mutant Vc1 RNAs. Consistent with the
in vivo data shown in Fig 2, the G12U mutation in Vc1 RNA significantly diminished seques-
tration of c-di-GMP, but did not fully eliminate it, unlike the equivalent mutation in Vc2 (Fig
4A). That the Vc1G12U mutant RNA retained some ability to sequester c-di-GMP32 indicates
that this residue is not absolutely required for c-di-GMP binding. However, the A39U and
C104G mutations, which did not substantially impact GbpA production, abolished the ability
of Vc1 to sequester c-di-GMP (Fig 4A).
We next examined the specificity of Vc1 for c-di-GMP using a two-step equilibrium dialysis
binding experiment. Vc1, as well as the Vc2 positive control, were allowed to interact with
radiolabeled c-di-GMP for 10 hours as described above, and the proportion of c-di-GMP
sequestered in the RNA-containing chamber was measured. As above, Vc2 sequestered c-di-
GMP32 to a greater extent than Vc1 (Fig 4B, black bars). For the second step, the non-seques-
tered radiolabeled c-di-GMP was removed, and excess non-radiolabeled (“cold”) c-di-GMP or
GTP was added. After an additional 10 hours to allow binding and potential displacement of c-
di-GMP32 from the first step, the remaining radioactivity associated with the RNA was
assessed. For Vc1, the addition of unlabeled c-di-GMP, but not unlabeled GTP, competed with
radiolabeled c-di-GMP for binding with Vc1 and shifted the distribution of c-di-GMP32, indi-
cating that the interaction between c-di-GMP and Vc1 is specific (Fig 4B). Interestingly, addi-
tion of unlabeled c-di-GMP did not compete with c-di-GMP32 for Vc2 binding over the
timescale of the dialysis assay, consistent with previous work showing that c-di-GMP dissoci-
ates very slowly from the Vc2 RNA [37]. Vc1 appears to have a faster off rate than Vc2, as c-di-
GMP32 could be displaced by the added unlabeled c-di-GMP over the 10 hour time course of
the assay.
Decreasing intracellular c-di-GMP reduces Vc1-dependent gene
expression
The data presented above suggest that c-di-GMP signaling through Vc1 promotes downstream
gene expression. We therefore determined the effect of altering the intracellular c-di-GMP con-
centration on GbpA production, using plasmid-borne, inducible diguanylate cyclase (pDGC)
and phosphodiesterase (pPDE) enzymes to artificially increase or decrease intracellular c-di-
GMP levels in V. cholerae, respectively [7,25]. For this study, the gbpA 5’UTR containing Vc1
was fused to a lacZ reporter gene and placed under the control of the constitutive PlacUV5 pro-
moter [38]. We chose a constitutive promoter based on findings that c-di-GMP levels can
impact the activity of the native gbpA promoter [33]. This translational reporter was integrated
into the V. cholerae chromosome within the native lacZ gene, generating the “PlacUV5-
Vc1UTR-lacZ” strain. Thus, the response of the Vc1 element to c-di-GMP could be assessed in
isolation from the native promoter and downstream gene, in single copy. A promoterless gbpA
5’ Vc1UTR-lacZ fusion strain served as a control to ensure that sequences within the 5’UTR
do not initiate transcription. pDGC, pPDE, pPDEmut and control vector were introduced into
the reporter strains to allow manipulation of c-di-GMP as described [7,25]. As expected, the
strains with the promoterless fusion had low β-galactosidase activity, regardless of c-di-GMP
level (S3 Fig). The V. cholerae PlacUV5-Vc1UTR-lacZ strain with reduced intracellular c-di-
GMP (pPDE, + L-arabinose) showed a greater than 50% decrease in β-galactosidase activity
compared to V. cholerae with wild-type levels of c-di-GMP (vector, + L-arabinose) (Fig 5A).
Conversely, increasing intracellular c-di-GMP through the ectopic production of a diguanylate
cyclase (pDGC, VCA0956) significantly increased β-galactosidase activity (S3 Fig). In addition,
expression from pPDEmut, in which a glutamic acid residue essential for PDE activity of the
VieA PDE has been mutated to an alanine (VieA-E170A) [7], resulted in no change in β-
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galactosidase activity, indicating that altered expression is specifically due to decreased c-di-
GMP (S3 Fig).
Next, we examined V. cholerae strains containing a derivative of PlacUV5-Vc1UTR-lacZ in
which the Vc1 sequence contains the G12T mutation (PlacUV5-Vc1UTR
G12T-lacZ) or A39T
mutation (PlacUV5-Vc1UTR
A39T-lacZ) for altered gene expression in response to c-di-GMP
depletion. In the Vc1G12T reporter strain, β-galactosidase activity is reduced compared to that
of V. cholerae with the wild type PlacUV5-Vc1UTR-lacZ fusion even in the absence of c-di-GMP
manipulation (Fig 5A, grey bars). When compared to wild type c-di-GMP levels, depleting c-
di-GMP does not further reduce reporter activity (Fig 5A). In contrast, the Vc1A39T reporter
strain showed activity comparable to the wild type reporter strain in the absence of c-di-GMP
manipulation, and activity remained at those levels when c-di-GMP levels were depleted.
These results suggest that decreasing c-di-GMP availability in the cell has a similar effect as the
G12 mutation, supporting a role for Vc1 in gbpA expression in response to c-di-GMP. Further-
more, the A39T mutation did not abrogate downstream gene expression, consistent with the in
vivo data shown in Fig 2.
Mutation of a residue important for ligand binding by Vc1 and depletion of the c-di-GMP
ligand both resulted in the significant reduction of downstream gene expression. We thus
examined the responsiveness of Vc1 to a range of c-di-GMP concentrations. This was done by
growing the PlacUV5-Vc1UTR-lacZ reporter strain containing pPDE in medium with different
concentrations of arabinose inducer; the consequent range of PDE production is expected to
result in a range of c-di-GMP levels. The PlacUV5-Vc1UTR-lacZ reporter strain with vector
served as a negative control, and the addition of arabinose did not affect β-galactosidase activity
in this strain. For the strain bearing pPDE, β-galactosidase activity decreased in a dose-depen-
dent fashion, with a gradual reduction in activity as PDE production increased and c-di-GMP
level decreased (Fig 5B). Thus, the Vc1 element may modulate downstream gene expression in
accordance with c-di-GMP levels in the cell.
Fig 5. Lowering intracellular c-di-GMP reduces Vc1-dependent gene expression. β-galactosidase activity of V. cholerae strains with chromosomal,
translational fusions of E. coli lacZ to the gbpA 5’ UTR with wild type Vc1, Vc1G12T, or Vc1A39T, with transcription initiation under the control of the constitutive
PlacUV5 promoter: PlacUV5-Vc1UTR-lacZ, PlacUV5-Vc1UTR
G12T-lacZ, PlacUV5-Vc1UTRA39T-lacZ, respectively [38]. Each reporter strain carried pPDE and
was grown without arabinose (wild-type c-di-GMP level; white bars) or with 0.2% arabinose (reduced c-di-GMP; black bars). (B) Dose response analysis
using the PlacUV5-Vc1UTR-lacZ reporter strain, with vector or pPDE, grown in rich medium with a range of arabinose concentrations. Increasing PDE
production corresponds with decreasing intracellular c-di-GMP. (A and B) Measurements of β-galactosidase activity were done with at least three
independent biological samples, and the means and standard error are shown. * P < 0.05, *** P < 0.001, n.s. = not significant by one-way ANOVA and
Bonferroni’s multiple comparison test.
doi:10.1371/journal.pone.0148478.g005
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Discussion
Cyclic diguanylate (c-di-GMP) has pleiotropic effects on bacterial physiology and broadly
impacts gene expression. With the exception of a handful of transcription factors that have
been shown to regulate gene expression in response to c-di-GMP, the molecular basis of gene
regulation by c-di-GMP is poorly understood. The identification of c-di-GMP specific ribos-
witches distributed widely among bacterial genomes positions these regulatory RNA domains
to serve as important c-di-GMP effectors modulating downstream gene expression. Elegant
studies have biochemically characterized a representative GEMM riboswitch, Vc2 from Vibrio
cholerae, but the functionality of c-di-GMP riboswitches in their native genetic contexts has
been largely unexplored. This study investigates the in vivo and in vitro functionality of the
putative c-di-GMP riboswitch Vc1 from V. cholerae.
Several lines of evidence support a role for Vc1 in sensing c-di-GMP in V. cholerae. Of key
importance is the finding that the Vc1 sequence itself influences gene expression in cis, in
response to changes in c-di-GMP. Specifically, isolating the Vc1 sequence by fusing it to a
reporter gene (lacZ), placing it under the transcriptional control of a heterologous, constitutive
promoter, and integrating it in the V. cholerae chromosome rendered reporter activity regula-
table by c-di-GMP. Moreover, mutating a single residue in the Vc1 sequence, the G12 nucleo-
tide predicted to be involved in c-di-GMP binding, eliminated regulation of downstream
expression by c-di-GMP. These findings are supported by independent experiments showing
that the same mutation at the native gbpA locus inhibited downstream gene expression.
SHAPE and equilibrium dialysis studies using Vc1 RNA corroborate a direct interaction
between Vc1 and c-di-GMP. In addition, equilibrium dialysis assays showed that the G12
mutation that reduced downstream gene expression similarly diminished the interaction
between Vc1 and c-di-GMP, and mutation of two other conserved putative ligand-binding res-
idues in Vc1, A39 and C104, abolished the ability of Vc1 to interact with c-di-GMP. Together
these results support a role for the Vc1 element in regulation of gbpA expression in response to
c-di-GMP, and point to Vc1 functioning as an “on” switch in response to c-di-GMP.
However, some of our results suggest that Vc1 does not fully behave as a canonical GEMM
riboswitch. For example, the equilibrium dialysis data suggest that despite conservation of key
residues, the interaction between c-di-GMP and Vc1 is much weaker than that with Vc2. This
is supported by assessments of c-di-GMP binding using a differential radial capillary action of
ligand assay (DRaCALA), which showed binding of c-di-GMP32 by Vc2 RNA as described pre-
viously, but failed to show a substantial interaction between Vc1 and c-di-GMP32 (data not
shown). In addition, previous analyses of Vc2 showed that mutating G20 reduced binding of c-
di-GMP by 30,000-fold [37], but mutating the equivalent G12 residue did not fully eliminate c-
di-GMP binding according to equilibrium dialysis. The high amount of RNA needed for these
assays suggests only a fraction of the RNA assumed a conformation competent for ligand bind-
ing under the conditions used. Further differentiating Vc1 from Vc2, the addition of excess,
non-radiolabelled competitor c-di-GMP to the equilibrium chambers led to displacement of
pre-bound c-di-GMP32 from Vc1, but not from Vc2. These results suggest that binding of c-di-
GMP by Vc1 is reversible, which may allow for more rapid and dynamic modulation of GbpA
production. Together, in vitro and in vivo analyses of Vc1 suggest that although it may be a
poor c-di-GMP binding riboswitch relative to Vc2, the Vc1 sequence is capable of regulating
downstream gene expression in response to c-di-GMP. Other putative c-di-GMP riboswitches
may also vary in their interactions with and responses to c-di-GMP.
Comparing in vitro and in vivo data, the Vc1 G12T, A39T and C104G mutations signifi-
cantly reduce or eliminate the interaction with c-di-GMP in vitro; however, downstream gene
expression in vivo was only significantly decreased by the G12T mutation. One interpretation
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of these results is that the involvement of particular residues in binding c-di-GMP may not
directly correlate to a role in downstream gene expression. Alternatively, it is possible that the
G12T mutant mimics the Vc1 “off” state, whereas the A39T and C104G mutants mimic the
Vc1 “on” state. Thus, while each mutation would decrease the interaction of Vc1 with c-di-
GMP, divergent effects on downstream gene expression could occur. This idea is supported by
in vivo experiments using isolated wild type and mutant Vc1 sequences fused to a lacZ reporter,
under the control of a heterologous, constitutive promoter; here, expression under the control
of the Vc1A39T UTR was comparable to that of the wild type riboswitch and remained so upon
perturbation of c-di-GMP levels. These results are consistent with the finding that the A39T
mutation on the V. cholerae chromosome did not attenuate GbpA levels. The Vc2 riboswitch,
while well studied in vitro, has not been examined for functionality in vivo, so it is unclear what
effect the G20, A47 and C92 mutations have on downstream gene expression for comparison.
In vivo experiments using the PlacUV5-Vc1UTR-lacZ fusion, which isolates the regulatory
function of Vc1, revealed that Vc1 is capable of controlling gene expression in a dose-depen-
dent manner according to a spectrum of c-di-GMP levels in the cell. The ability of Vc1 to
respond to a range of c-di-GMP levels is consistent with prior work using a reporter controlled
by an engineered c-di-GMP riboswitch, which also suggested that reporter activity varied
depending on intracellular c-di-GMP levels [39]. In Salmonella Typhimurium, various proteins
that sense c-di-GMP to control motility and biofilm production also bind c-di-GMP with dif-
ferent affinities [40]. This study suggests that sequential activation of these receptors to chang-
ing c-di-GMP concentrations is important to mediate a progressive response. V. cholerae
encodes 61 genes with predicted functions as PDE and/or DGC enzymes, a subset of which
likely modulate c-di-GMP levels to presumably achieve a range of c-di-GMP levels in response
to environmental stimuli. Therefore, the ability of Vc1 to respond to varying intracellular c-di-
GMP concentrations may allow for rapid changes in gbpA expression according to extracellular
cues.
Regulation via a riboswitch typically occurs as a result of ligand-induced conformational
changes in the RNA structure [41,42]. Most commonly, riboswitches regulate gene expression
through the formation of structures that control either premature transcriptional termination
or translational initiation. There are no apparent Rho-independent transcription terminator or
anti-Shine Delgarno sequences between Vc1 and the gbpA open reading frame, so the mecha-
nism by which Vc1 regulates gbpA expression is unclear. Future work will determine whether
Vc1 controls transcriptional read-through, translation initiation or transcript stability. The
mechanism by which the Vc2 riboswitch regulates VC1722 expression is similarly unknown.
Several lines of evidence suggest that c-di-GMP levels change in V. cholerae during transi-
tions between its native aquatic environment and the host intestine. For example, V. cholerae
forms biofilms on surfaces in the environment, such as the chitin, and numerous studies have
shown that biofilm formation is positively regulated by c-di-GMP [25,43,44]. Furthermore,
increased intracellular c-di-GMP enhances the binding of V. cholerae to chitin in vitro in a pro-
cess dependent on the hemagglutinin FrhA [45]. Conversely, reduction of c-di-GMP is
required to promote bacterial motility and increase expression of virulence factors in the intes-
tinal tract [25,43,44]. In the context of V. cholerae biology, the effect of c-di-GMP sensing by
Vc1 to augment GbpA production may contribute to colonization of environmental (chitin)
and host surfaces. Yet determining the role of c-di-GMP in controlling c-di-GMP—regulated
processes of V. cholerae is complicated by the finding that the gbpA promoter is negatively reg-
ulated by c-di-GMP [33]. Additional work is needed to define the roles of Vc1 and Vc2 in mod-
ulating c-di-GMP-regulated processes in response to extracellular cues in V. cholerae.
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